• Core Excipients

  • Functional Excipients for the Formulation of Solid Oral Dosage Forms

  • Coatings

  • Fully Formulated Conventional and Modified Release Film Coating Systems
  • Formulation Tools

  • Useful Tools for the Pharmaceutical Formulator

  • Education

  • Technical formulation and development seminars and forums
  • Evaluate

  • Competitor, Consumer Color Preference, Regulatory, Tablet Library of Shapes, and Trademarks

  • Develop

  • Unique Tablet Designs and Branding Solutions

  • Visualize

  • Concept to Prototypes using State-of-the-Art 3D Images and Models through our Tablet Design Centers

  • Brand Security

  • Understand Options and Learn of New Technologies to Protect your Brand
  • Technical

  • Global Technical Support, Technical Service Labs and Tablet Design Centers

  • Regulatory

  • Global Regulatory Support Services

  • Customer

  • Global Customer Support and Service Locations
  • Tools

  • Useful Tools to Assist Pharmaceutical Product Development

  • Literature

  • Extensive Collection of Articles, Product Literature, Application Data and Regulatory Documents

  • Education

  • Technical Formulation and Development Seminars and Forums
 

Biphasic Release

In certain conditions (migraine and sleeping disorders), drug treatment may be advantageous to be delivered in a bi-phasic manner rather than a single phase extended release preparation. In the first phase of drug release, the immediate release dose fraction (also called “loading-dose”) reaches a therapeutic drug level in the blood plasma quickly after administration, while the second extended release phase (called the “maintenance-dose”) provides the dose fraction, required to maintain an effective therapeutic level for a prolonged period. Examples of such systems can be found as bilayer tablets, drug layered matrices, or combinations of immediate, and extended release multi-particulates.

 
Update My Binder
Published Posters